Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Gross Margin (2016 - 2026)

Healthequity has reported Gross Margin over the past 14 years, most recently at 68.19% for Q1 2026.

  • Quarterly results put Gross Margin at 68.19% for Q1 2026, up 756.0% from a year ago — trailing twelve months through Jan 2026 was 69.52% (up 474.0% YoY), and the annual figure for FY2026 was 69.52%, up 474.0%.
  • Gross Margin for Q1 2026 was 68.19% at Healthequity, down from 70.79% in the prior quarter.
  • Over the last five years, Gross Margin for HQY hit a ceiling of 71.38% in Q3 2025 and a floor of 51.95% in Q1 2022.
  • Median Gross Margin over the past 5 years was 62.27% (2023), compared with a mean of 62.75%.
  • Biggest five-year swings in Gross Margin: tumbled -198bps in 2022 and later soared 756bps in 2026.
  • Healthequity's Gross Margin stood at 58.92% in 2022, then increased by 8bps to 63.87% in 2023, then grew by 3bps to 65.58% in 2024, then increased by 8bps to 70.79% in 2025, then decreased by -4bps to 68.19% in 2026.
  • The last three reported values for Gross Margin were 68.19% (Q1 2026), 70.79% (Q4 2025), and 71.38% (Q3 2025) per Business Quant data.